To date, a number of newer classes of medications used to treat T2D have been developed and subsequently released to market that effectively lower glucose levels while minimizing the risk of hypoglycemia and inducing weight loss
Angew Chem Int Ed 47(33):61726176 Zhang H, Liu R, Liu J, Li L, Wang P, Yao SQ, Xu Z, Sun H (2016) A minimalist fluorescent probe for differentiating Cys, Hcy and GSH in live cells
According to the ASCPA Animal Poison Control Center (APCC), pets most commonly gain access to GLP-1 medications through: Chewing on pre-filled injection pens/vials* or ingesting oral tablet formulations
(Note: This reference is included as comparative context for myostatin regulation mechanisms) Malaguarnera M, et al
Nonthermal activation of transient receptor potential vanilloid-1 channels in abdominal viscera tonically inhibits autonomic cold-defense effectors